Pharmacokinetics of buspirone as determined by ex vivo (3H)-DPAT binding
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (10), 1045-1048
- https://doi.org/10.1016/0024-3205(88)90559-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- 5-HT1A receptor-related anxiolyticsTrends in Pharmacological Sciences, 1987
- Onset and duration of action of benzodiazepines as determined by inhibition of (3H)‐flunitrazepam bindingDrug Development Research, 1987
- Metabolism and disposition of buspironeAmerican Journal Of Medicine, 1986
- Serotonergic mechanisms in the behavioral effects of buspirone and gepironePharmacology Biochemistry and Behavior, 1986
- Selective labeling of 5-HT1A and 5-HT1B binding sites in bovine brainBrain Research, 1985
- Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptorsBiological Psychiatry, 1985
- [3H]8‐Hydroxy‐2‐(Di‐n‐Propylamino)Tetralin Binding to Pre‐ and Postsynaptic 5‐Hydroxytryptamine Sites in Various Regions of the Rat BrainJournal of Neurochemistry, 1985
- Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PATNature, 1983
- Interaction of triazolobenzodiazepines with benzodiazepine receptorsJournal of Pharmacy and Pharmacology, 1983
- A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of the benzodiazepinesProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1983